Capio AB (publ) (OM:CAPIO) plans to sell Capio Sante SA to Vivalto Santé SAS in a deal worth up to €455 million to focus on its less capital intensive Nordic operations. “The proposed transaction would accelerate the positioning towards the less capital intensive Nordic operations and build on Capio’s leadership positions to further drive growth and shareholder value”, Capio said in a statement. The consideration for the proposed deal would be an upfront enterprise value of €425 million plus an earn-out contingent on this year’s financial performance, up to a total enterprise value of €455 million. The deal is subject to due diligence of Capio France by Vivalto, the approval of regulatory authorities and the approval of Capio’s shareholders at an extraordinary general meeting, it said. “It is anticipated that proceeds from a sale would be used partly to pay down Capio Group debt and partly as a return of cash to shareholders”, the company said. Capio shares were up 1.75%.